Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03316053 · ClinicalTrials.gov registry record
Cell Marker Predictors in Barrett's Esophagus
A clinical trial of Barrett's Esophagus Without Dysplasia, sponsored by The Guthrie Clinic.
- Active
- Registry status
- 25
- Enrollment target
- 1
- Study location
NCT03316053 is a study of Barrett's Esophagus Without Dysplasia that is active but no longer recruiting, run by The Guthrie Clinic. The registered enrollment target is 25 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03316053, a study of Barrett's Esophagus Without Dysplasia, is active but no longer recruiting, sponsored by The Guthrie Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to analyze biopsied tissue samples for changes in cells and genes involved in Barrett's Esophagus.
Conditions Studied
Interventions
- OTHER Tissue sample for genetic testing
Study Locations (1)
Pennsylvania
- The Guthrie Clinic - Sayre
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2017-11-15 |
| Est. Completion | 2027-12-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03316053
The ClinicalTrials.gov registry entry for NCT03316053 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Guthrie Clinic, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Barrett's Esophagus Without Dysplasia appearing as the primary indexed condition, and to 1 intervention - of which Tissue sample for genetic testing is the first listed.
NCT03316053 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03316053 about?
NCT03316053 is a clinical study titled "Cell Marker Predictors in Barrett's Esophagus". The purpose of this study is to analyze biopsied tissue samples for changes in cells and genes involved in Barrett's Esophagus.
What is the current status of trial NCT03316053?
This trial is currently active not recruiting. The enrollment target is 25 participants. The study started on 2017-11-15. Estimated completion is 2027-12-01.
What conditions does trial NCT03316053 study?
This clinical trial studies the following conditions: Barrett's Esophagus Without Dysplasia.
What interventions are being tested in trial NCT03316053?
The interventions under investigation include: Tissue sample for genetic testing (OTHER).
Who is sponsoring clinical trial NCT03316053?
This trial is sponsored by The Guthrie Clinic, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03316053 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Barrett's Esophagus Without Dysplasia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.